GENMINE Trademark

Trademark Overview

On Friday, August 6, 2021, a trademark application was filed for GENMINE with the United States Patent and Trademark Office. The USPTO has given the GENMINE trademark a serial number of 90868815. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, June 18, 2025. This trademark is owned by Konica Minolta, Inc.. The GENMINE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical screening for cancer; medical testing services for diagnostic or treatment purposes for cancer; DNA screening for medical purposes
genmine

General Information

Serial Number90868815
Word MarkGENMINE
Filing DateFriday, August 6, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, June 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Goods and ServicesMedical screening for cancer; medical testing services for diagnostic or treatment purposes for cancer; DNA screening for medical purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKonica Minolta, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 100-7015
JP
Party NameKonica Minolta, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-7015
JP

Trademark Events

Event DateEvent Description
Thursday, September 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 4, 2021ASSIGNED TO LIE
Wednesday, November 17, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 17, 2021NON-FINAL ACTION E-MAILED
Wednesday, November 17, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 10, 2021NEW APPLICATION ENTERED
Monday, August 23, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, October 5, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Tuesday, May 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 13, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, June 13, 2022EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2022EXAMINER'S AMENDMENT ENTERED
Monday, June 13, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Thursday, March 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 2, 2023SOU EXTENSION 1 FILED
Thursday, March 2, 2023SOU EXTENSION 1 GRANTED
Saturday, March 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 2 FILED
Wednesday, August 23, 2023SOU EXTENSION 2 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 26, 2024SOU EXTENSION 3 FILED
Monday, February 26, 2024SOU EXTENSION 3 GRANTED
Monday, August 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU EXTENSION 4 GRANTED
Monday, February 26, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 5, 2024SOU EXTENSION 4 FILED
Thursday, February 27, 2025SOU EXTENSION 5 FILED
Friday, February 28, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 18, 2025SOU EXTENSION 5 GRANTED
Wednesday, June 18, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

genmine medical purposes cancer screening treatment testing services diagnostic